Human hepatitis B virus-derived virus-like particle as a drug and DNA delivery carrier.

[1]  M. Fujimuro,et al.  Kaposi's sarcoma-associated herpesvirus ORF17 plays a key role in capsid maturation. , 2021, Virology.

[2]  Wilfred Chen,et al.  Modular Hepatitis B Virus-Like Particle Platform for Biosensing and Drug Delivery. , 2020, ACS nano.

[3]  E. Blanchard,et al.  Hepatitis B Virus Entry into Cells , 2020, Cells.

[4]  M. Fujimuro,et al.  MG132 exerts anti-viral activity against HSV-1 by overcoming virus-mediated suppression of the ERK signaling pathway , 2020, Scientific Reports.

[5]  Jianxiang Zhang,et al.  Surface engineering of nanomaterials with phospholipid-polyethylene glycol-derived functional conjugates for molecular imaging and targeted therapy. , 2019, Biomaterials.

[6]  M. Seno,et al.  Synthesis and assembly of Hepatitis B virus envelope protein-derived particles in Escherichia coli. , 2017, Biochemical and biophysical research communications.

[7]  T. Liang,et al.  Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions. , 2017, Journal of hepatology.

[8]  M. Fälth,et al.  Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. , 2014, Gastroenterology.

[9]  Hussein H. Aly,et al.  Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. , 2014, Biochemical and biophysical research communications.

[10]  X. Wu,et al.  Nanotechnological advances for the delivery of CNS therapeutics. , 2012, Advanced drug delivery reviews.

[11]  Wenhui Li,et al.  Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. , 2012, eLife.

[12]  J. Wands,et al.  Impairment of Hepatitis B Virus Virion Secretion by Single-Amino-Acid Substitutions in the Small Envelope Protein and Rescue by a Novel Glycosylation Site , 2010, Journal of Virology.

[13]  S. Urban,et al.  Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. , 2005, Gastroenterology.

[14]  S. Urban,et al.  Efficient Inhibition of Hepatitis B Virus Infection by Acylated Peptides Derived from the Large Viral Surface Protein , 2004, Journal of Virology.

[15]  W. Gerlich,et al.  Pre-S1 Antigen-Dependent Infection of Tupaia Hepatocyte Cultures with Human Hepatitis B Virus , 2003, Journal of Virology.

[16]  A. Kondo,et al.  Nanoparticles for the delivery of genes and drugs to human hepatocytes , 2003, Nature Biotechnology.

[17]  R. Perez-soler,et al.  Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells. , 1996, Molecular pharmacology.

[18]  K. Matsubara,et al.  Three envelope proteins of hepatitis B virus: large S, middle S, and major S proteins needed for the formation of Dane particles , 1991, Journal of virology.

[19]  D. Ganem,et al.  The role of envelope proteins in hepatitis B virus assembly. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D. Ganem,et al.  Assembly of hepadnaviral virions and subviral particles. , 1991, Current topics in microbiology and immunology.

[21]  H. Varmus,et al.  The molecular biology of the hepatitis B viruses. , 1987, Annual review of biochemistry.

[22]  H. Varmus,et al.  Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide. , 1986, Science.

[23]  R. Palmiter,et al.  Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice , 1986, Journal of virology.

[24]  W. Gerlich,et al.  Large surface proteins of hepatitis B virus containing the pre-s sequence , 1984, Journal of virology.

[25]  M. Hilleman,et al.  Human hepatitis B vaccine from recombinant yeast , 1984, Nature.